Rxo (RXO) Other Accumulated Expenses (2021 - 2026)

Rxo (RXO) has 6 years of Other Accumulated Expenses data on file, last reported at $10.0 million in Q1 2026.

• Quarterly Other Accumulated Expenses fell 9.09% year-over-year to $10.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.0 million (down 9.09% YoY) and the FY2025 annual result came in at $10.0 million, down 61.54% from the prior year.
• Other Accumulated Expenses held at $10.0 million in Q1 2026, from $10.0 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $26.0 million in Q4 2024 to a low of $5.0 million in Q3 2022.
• A 5-year average of $12.1 million and a median of $12.0 million in 2024 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2024 — Other Accumulated Expenses soared 283.33% — and 2025, when it sank 61.54%.
• Tracing RXO's Other Accumulated Expenses over 5 years: stood at $14.0 million in 2022, then retreated by 7.14% to $13.0 million in 2023, then surged by 100.0% to $26.0 million in 2024, then slumped by 61.54% to $10.0 million in 2025, then changed by 0.0% to $10.0 million in 2026.
• The last three Other Accumulated Expenses figures came in at $10.0 million (Q1 2026), $10.0 million (Q4 2025), and $12.0 million (Q3 2025), per Business Quant data.